Chordia Therapeutics' Series A Round

Chordia Therapeutics raised a round of funding on November 23, 2017.

Chordia Therapeutics is a biotechnology company spun off from Takeda. Chordia's programs include preclinical CDC-like kinase (CLK) inhibitors with applications in cancer and an adult T cell leukemia l…

Articles about Chordia Therapeutics' Series A Round: